The form is in the binder. The box is checked. On to the next task.

This is one of the most pervasive misunderstandings in clinical research. Not a violation, usually. Not an act of negligence. Something more subtle and, in some ways, more dangerous: a failure of conceptual framing. The site team has internalized consent as an event -- a moment in time with a clear beginning (opening the form) and a clear end (collecting the signature). And once the event is over, consent is over.

It is not over. It has not even fully begun.

The signature on an informed consent form is not a finish line. It is a starting line. What follows -- every study visit, every safety update, every protocol amendment, every moment a participant weighs whether to continue -- is part of the consent process. Not metaphorically. Regulatorily. ICH E6(R3) does not treat consent as a one-time event, and neither should the professionals who conduct it.

This lesson establishes the conceptual framework for understanding consent as an ongoing process. We will distinguish between the event model and the process model, examine what ICH E6(R3) Section 2.8.2 actually requires, and identify the touchpoints where ongoing consent obligations arise throughout trial participation. This is the intellectual foundation. In Module 6, you will learn to operationalize every concept introduced here -- the specific procedures, logistics, and documentation for reconsent and ongoing communication. But first, you need the framework. You need to see the whole landscape before you can navigate it.

The form is in the binder. The box is checked. On to the next task.

This is one of the most pervasive misunderstandings in clinical research. Not a violation, usually. Not an act of negligence. Something more subtle and, in some ways, more dangerous: a failure of conceptual framing. The site team has internalized consent as an event -- a moment in time with a clear beginning (opening the form) and a clear end (collecting the signature). And once the event is over, consent is over.

It is not over. It has not even fully begun.

The signature on an informed consent form is not a finish line. It is a starting line. What follows -- every study visit, every safety update, every protocol amendment, every moment a participant weighs whether to continue -- is part of the consent process. Not metaphorically. Regulatorily. ICH E6(R3) does not treat consent as a one-time event, and neither should the professionals who conduct it.

This lesson establishes the conceptual framework for understanding consent as an ongoing process. We will distinguish between the event model and the process model, examine what ICH E6(R3) Section 2.8.2 actually requires, and identify the touchpoints where ongoing consent obligations arise throughout trial participation. This is the intellectual foundation. In Module 6, you will learn to operationalize every concept introduced here -- the specific procedures, logistics, and documentation for reconsent and ongoing communication. But first, you need the framework. You need to see the whole landscape before you can navigate it.